Jpm 2025 Agenda Google. Fierce jpm week | 2025 speakers 2025 speakers are coming soon! To be sure, headwinds still face biotech and pharma companies from a range of challenges, including sustained high interest rates, ongoing geopolitical tensions, and the.
Follow here for live updates from the second day. Executives at fertility startup kindbody said the company is on track to be ebitda positive in 2025 and free cash flow positive in late 2025 or early 2025.